Paul Hooper and Nathan Ludvigson

Paul Hooper
Emdeon VP Pharmacy Network Services
As VP pharmacy network services at Emdeon, Paul Hooper directs the company’s pharmacy network services initiatives with a focus on developing programs, standards and partnerships that increase pharmacy efficiency and reduce healthcare costs.

Paul has spent more than 25 years in the healthcare industry with a predominant focus in pharmacy. During this time, he has held roles in product development, systems, finance and operations at various recognized industry leaders: BASF, Abbott Laboratories, Cardinal Health, ArcLight and Emdeon. 

He holds a master's degree in business administration from Ohio University and a bachelor of science in food science from Pennsylvania State University.

Nathan Ludvigson
Emdeon Manager of Government Business Development, Pharmacy Services
As manager of government business development with Emdeon, Nathan Ludvigson directs policy and business development for pharmacy services related to electronic prescribing; health information exchange (HIE); medication therapy management (MTM); prescription monitoring programs (PMP); durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS); in addition to supporting Emdeon’s participation with the Massachusetts electronic prescribing of controlled substances (EPCS-MA) research project. Ludvigson combines extensive pharmacy industry experience with legislative policy experience in both the U.S. Congress and Texas Senate. He earned his bachelor of science degree in political science from Texas Christian University and a master’s degree in public administration from the University of Houston.

Articles by this author:

  • Wed, 02/15/2012 - 12:00pm
    Regulators, healthcare providers and the public at large have taken note of the rise in prescription drug substance abuse. A recent article titled "Oxycodone Prescriptions Rose Sharply" in the New York Times (1/11/2012) describes trends of double-digit percentage increases in the dispensing of certain narcotic based painkillers. And many states have, or will be, implementing prescription drug monitoring programs — also known as prescription monitoring programs — that track the physicians prescribing and the patients receiving controlled substances.